USE OF A PEPTIDE AS A THERAPEUTIC AGENT

摘要

The present invention is directed to the use of the combination of the Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-lle-Leu-OH and Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 as a therapeutic combination for prophylaxis and/or treatment of cancer, a heart and vascular disease, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, or an autoimmune disease.